menu ☰
menu ˟

FDA accepts NDA for tazarotene lotion for acne

08 Aug 2019
The FDA has accepted a new drug application for IDP-123, a lotion for the treatment of acne, according to an announcement from Bausch Health and Ortho Dermatologics, Bausch’s dermatology business.The NDA for IDP-123 (tazarotene 0.045%) includes dat...

Click here to view the full article which appeared in Dermatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.